| |
| |
|
| Insider
Information: |
Colella Samuel D |
| Relationship: |
Director |
| City: |
Santa Clara |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
203,276 |
|
|
Indirect Shares
|
2,453,199 |
|
|
| Direct
Value |
$757,044 |
|
|
|
Indirect Value
|
$21,071,279 |
|
|
| Total
Shares |
2,656,475 |
|
|
| Total
Value |
$21,828,323 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 130.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genomic Health Inc |
GHDX |
Director |
2014-10-01 |
5,305 |
2014-10-01 |
54,348 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2010-01-26 |
36,862 |
2010-01-26 |
2,183,128 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2006-05-15 |
13,713 |
Premium* |
|
|
Insulet Corp |
PODD |
Former 10% Owner |
2007-05-14 |
0 |
2007-05-14 |
89,372 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2007-06-06 |
0 |
2008-07-21 |
13,247 |
Premium* |
|
|
Fluidigm Corp |
FLDM |
Director |
2020-03-11 |
161,109 |
2020-03-11 |
78,159 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
Director, 10% Owner |
2013-11-04 |
0 |
2013-11-04 |
21,232 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Director |
2021-11-19 |
0 |
2021-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FLDM |
Fluidigm Corp |
Director |
– • – |
2013-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
1,264 |
1,264 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2013-10-01 |
4 |
A |
$30.33 |
$9,979 |
D/D |
329 |
3,880 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • • |
2013-11-04 |
4 |
A |
$0.00 |
$0 |
I/I |
3,616,221 |
21,232 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2013-11-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,063 |
18,940 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2013-11-04 |
4 |
A |
$0.00 |
$0 |
I/I |
4,030 |
5,294 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2013-11-04 |
4/A |
A |
$0.00 |
$0 |
I/I |
4,297 |
5,561 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2013-11-04 |
4/A |
A |
$0.00 |
$0 |
D/D |
8,796 |
19,673 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2014-01-01 |
4 |
A |
$29.27 |
$9,981 |
D/D |
341 |
4,221 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,793,335 |
2,899,115 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2014-04-01 |
4 |
A |
$26.57 |
$9,990 |
D/D |
376 |
4,597 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2014-07-01 |
4 |
A |
$27.86 |
$9,974 |
D/D |
358 |
4,955 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2014-10-01 |
4 |
A |
$28.54 |
$9,989 |
D/D |
350 |
5,305 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2017-05-24 |
4 |
A |
$0.00 |
$0 |
I/I |
3,326 |
3,326 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2018-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
12,830 |
71,923 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2018-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,100 |
86,023 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,748 |
95,771 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2019-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,987 |
99,758 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2020-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
21,628 |
141,109 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
30,004 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2021-01-15 |
4/A |
A |
$0.00 |
$0 |
I/I |
2,198 |
69,837 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
I/I |
671,060 |
943 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
11,198 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-15 |
4 |
B |
$0.00 |
$0 |
I/I |
230,769 |
2,044,744 |
1.42 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2008-07-21 |
4 |
B |
$0.00 |
$0 |
I/I |
296,022 |
13,247 |
2.02 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2014-02-18 |
4 |
B |
$13.00 |
$3,999,996 |
I/I |
307,692 |
3,206,807 |
2.25 |
- |
|
105 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
